US Patent Issued to INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), UNIVERSITE D'AIX MARSEILLE on Oct. 6 for "RNA sequencing method for the analysis of b and t cell transcriptome in phenotypically defined b and t cell subsets" (French Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,436, issued on Oct. 6, was assigned to INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (Paris), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (Paris) and UNIVERSITE D'AIX MARSEILLE (Marseilles, France).

"RNA sequencing method for the analysis of b and t cell transcriptome in phenotypically defined b and t cell subsets" was invented by Pierre Milpied (Marseilles, France), Noudjoud Attaf (Marseilles, France), Inaki Cervera-Marzal (Marseilles, France) and Laurine Gil (Marseilles, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "Single-cell RNA sequencing (scRNAseq) allows the identification, characterization, and quantifica...